1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Global Methadone Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 Global Methadone Market Landscape
5.1 Historical and Current Market Trends (2018-2023)
5.2 Market Forecast (2024-2032)
6 Global Methadone Market - Breakup by Mode of Administration
6.1 Oral Medicine
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2018-2023)
6.1.3 Market Segmentation
6.1.4 Market Forecast (2024-2032)
6.2 Injections
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2018-2023)
6.2.3 Market Segmentation
6.2.4 Market Forecast (2024-2032)
6.3 Attractive Investment Proposition by Mode of Administration
7 Global Methadone Market - Breakup by Therapeutic Area
7.1 Pain Treatment
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2018-2023)
7.1.3 Market Segmentation
7.1.4 Market Forecast (2024-2032)
7.2 Detoxification
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2018-2023)
7.2.3 Market Segmentation
7.2.4 Market Forecast (2024-2032)
7.3 Maintenance Therapy
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2018-2023)
7.3.3 Market Segmentation
7.3.4 Market Forecast (2024-2032)
7.4 Attractive Investment Proposition by Therapeutic Area
8 Global Methadone Market - Breakup by Distribution Channel
8.1 Hospital Pharmacies
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2018-2023)
8.1.3 Market Segmentation
8.1.4 Market Forecast (2024-2032)
8.2 Retail Pharmacies
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2018-2023)
8.2.3 Market Segmentation
8.2.4 Market Forecast (2024-2032)
8.3 Rehab Centers
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2018-2023)
8.3.3 Market Segmentation
8.3.4 Market Forecast (2024-2032)
8.4 Drug Stores
8.4.1 Overview
8.4.2 Historical and Current Market Trends (2018-2023)
8.4.3 Market Segmentation
8.4.4 Market Forecast (2024-2032)
8.5 Attractive Investment Proposition by Distribution Channel
9 Global Methadone Market – Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Drivers
9.1.1.2 Historical and Current Market Trends (2018-2023)
9.1.1.3 Market Breakup by Mode of Administration
9.1.1.4 Market Breakup by Therapeutic Area
9.1.1.5 Market Breakup by Distribution Channel
9.1.1.6 Key Players
9.1.1.7 Market Forecast (2024-2032)
9.1.2 Canada
9.1.2.1 Market Drivers
9.1.2.2 Historical and Current Market Trends (2018-2023)
9.1.2.3 Market Breakup by Mode of Administration
9.1.2.4 Market Breakup by Therapeutic Area
9.1.2.5 Market Breakup by Distribution Channel
9.1.2.6 Key Players
9.1.2.7 Market Forecast (2024-2032)
9.2 Europe
9.2.1 Germany
9.2.1.1 Market Drivers
9.2.1.2 Historical and Current Market Trends (2018-2023)
9.2.1.3 Market Breakup by Mode of Administration
9.2.1.4 Market Breakup by Therapeutic Area
9.2.1.5 Market Breakup by Distribution Channel
9.2.1.6 Key Players
9.2.1.7 Market Forecast (2024-2032)
9.2.2 France
9.2.2.1 Market Drivers
9.2.2.2 Historical and Current Market Trends (2018-2023)
9.2.2.3 Market Breakup by Mode of Administration
9.2.2.4 Market Breakup by Therapeutic Area
9.2.2.5 Market Breakup by Distribution Channel
9.2.2.6 Key Players
9.2.2.7 Market Forecast (2024-2032)
9.2.3 United Kingdom
9.2.3.1 Market Drivers
9.2.3.2 Historical and Current Market Trends (2018-2023)
9.2.3.3 Market Breakup by Mode of Administration
9.2.3.4 Market Breakup by Therapeutic Area
9.2.3.5 Market Breakup by Distribution Channel
9.2.3.6 Key Players
9.2.3.7 Market Forecast (2024-2032)
9.2.4 Italy
9.2.4.1 Market Drivers
9.2.4.2 Historical and Current Market Trends (2018-2023)
9.2.4.3 Market Breakup by Mode of Administration
9.2.4.4 Market Breakup by Therapeutic Area
9.2.4.5 Market Breakup by Distribution Channel
9.2.4.6 Key Players
9.2.4.7 Market Forecast (2024-2032)
9.2.5 Spain
9.2.5.1 Market Drivers
9.2.5.2 Historical and Current Market Trends (2018-2023)
9.2.5.3 Market Breakup by Mode of Administration
9.2.5.4 Market Breakup by Therapeutic Area
9.2.5.5 Market Breakup by Distribution Channel
9.2.5.6 Key Players
9.2.5.7 Market Forecast (2024-2032)
9.2.6 Others
9.2.6.1 Historical and Current Market Trends (2018-2023)
9.2.6.2 Market Forecast (2024-2032)
9.3 Asia Pacific
9.3.1 China
9.3.1.1 Market Drivers
9.3.1.2 Historical and Current Market Trends (2018-2023)
9.3.1.3 Market Breakup by Mode of Administration
9.3.1.4 Market Breakup by Therapeutic Area
9.3.1.5 Market Breakup by Distribution Channel
9.3.1.6 Key Players
9.3.1.7 Market Forecast (2024-2032)
9.3.2 Japan
9.3.2.1 Market Drivers
9.3.2.2 Historical and Current Market Trends (2018-2023)
9.3.2.3 Market Breakup by Mode of Administration
9.3.2.4 Market Breakup by Therapeutic Area
9.3.2.5 Market Breakup by Distribution Channel
9.3.2.6 Key Players
9.3.2.7 Market Forecast (2024-2032)
9.3.3 India
9.3.3.1 Market Drivers
9.3.3.2 Historical and Current Market Trends (2018-2023)
9.3.3.3 Market Breakup by Mode of Administration
9.3.3.4 Market Breakup by Therapeutic Area
9.3.3.5 Market Breakup by Distribution Channel
9.3.3.6 Key Players
9.3.3.7 Market Forecast (2024-2032)
9.3.4 South Korea
9.3.4.1 Market Drivers
9.3.4.2 Historical and Current Market Trends (2018-2023)
9.3.4.3 Market Breakup by Mode of Administration
9.3.4.4 Market Breakup by Therapeutic Area
9.3.4.5 Market Breakup by Distribution Channel
9.3.4.6 Key Players
9.3.4.7 Market Forecast (2024-2032)
9.3.5 Australia
9.3.5.1 Market Drivers
9.3.5.2 Historical and Current Market Trends (2018-2023)
9.3.5.3 Market Breakup by Mode of Administration
9.3.5.4 Market Breakup by Therapeutic Area
9.3.5.5 Market Breakup by Distribution Channel
9.3.5.6 Key Players
9.3.5.7 Market Forecast (2024-2032)
9.3.6 Indonesia
9.3.6.1 Market Drivers
9.3.6.2 Historical and Current Market Trends (2018-2023)
9.3.6.3 Market Breakup by Mode of Administration
9.3.6.4 Market Breakup by Therapeutic Area
9.3.6.5 Market Breakup by Distribution Channel
9.3.6.6 Key Players
9.3.6.7 Market Forecast (2024-2032)
9.3.7 Others
9.3.7.1 Historical and Current Market Trends (2018-2023)
9.3.7.2 Market Forecast (2024-2032)
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Drivers
9.4.1.2 Historical and Current Market Trends (2018-2023)
9.4.1.3 Market Breakup by Mode of Administration
9.4.1.4 Market Breakup by Therapeutic Area
9.4.1.5 Market Breakup by Distribution Channel
9.4.1.6 Key Players
9.4.1.7 Market Forecast (2024-2032)
9.4.2 Mexico
9.4.2.1 Market Drivers
9.4.2.2 Historical and Current Market Trends (2018-2023)
9.4.2.3 Market Breakup by Mode of Administration
9.4.2.4 Market Breakup by Therapeutic Area
9.4.2.5 Market Breakup by Distribution Channel
9.4.2.6 Key Players
9.4.2.7 Market Forecast (2024-2032)
9.4.3 Others
9.4.3.1 Historical and Current Market Trends (2018-2023)
9.4.3.2 Market Forecast (2024-2032)
9.5 Middle East and Africa
9.5.1 Market Drivers
9.5.2 Historical and Current Market Trends (2018-2023)
9.5.3 Market Breakup by Mode of Administration
9.5.4 Market Breakup by Therapeutic Area
9.5.5 Market Breakup by Distribution Channel
9.5.6 Market Breakup by Country
9.5.7 Key Players
9.5.8 Market Forecast (2024-2032)
9.6 Attractive Investment Proposition by Region
10 Global Methadone Market – Competitive Landscape
10.1 Overview
10.2 Market Structure
10.3 Market Share by Key Players
10.4 Market Player Positioning
10.5 Top Winning Strategies
10.6 Competitive Dashboard
10.7 Company Evaluation Quadrant
11 Profiles of Key Players
11.1 Hikma Pharmaceuticals PLC
11.1.1 Business Overview
11.1.2 Product Portfolio
11.1.3 Business Strategies
11.1.4 Financials
11.1.5 SWOT Analysis
11.1.6 Major News and Events
11.2 Mallinckrodt Pharmaceuticals
11.2.1 Business Overview
11.2.2 Product Portfolio
11.2.3 Business Strategies
11.2.4 Financials
11.2.5 SWOT Analysis
11.2.6 Major News and Events
11.3 VistaPharm Inc. (Pharmaceutical Associates Inc.)
11.3.1 Business Overview
11.3.2 Product Portfolio
11.3.3 Business Strategies
11.3.4 SWOT Analysis
11.3.5 Major News and Events
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
12 Global Methadone Market - Industry Analysis
12.1 Drivers, Restraints, and Opportunities
12.1.1 Overview
12.1.2 Drivers
12.1.3 Restraints
12.1.4 Opportunities
12.1.5 Impact Analysis
12.2 Porters Five Forces Analysis
12.2.1 Overview
12.2.2 Bargaining Power of Buyers
12.2.3 Bargaining Power of Suppliers
12.2.4 Degree of Competition
12.2.5 Threat of New Entrants
12.2.6 Threat of Substitutes
12.3 Value Chain Analysis
13 Strategic Recommendations
14 Appendix